At close: 4:35:23 PM GMT
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
252,342.00
460,180.00
237,229.00
183,928.00
Total Liabilities Net Minority Interest
174,508.00
223,988.00
49,891.00
71,182.00
Total Equity Gross Minority Interest
77,834.00
236,192.00
187,338.00
112,746.00
Total Capitalization
112,540.00
244,433.00
187,338.00
112,746.00
Common Stock Equity
74,006.00
204,653.00
187,338.00
112,746.00
Capital Lease Obligations
72,924.00
74,501.00
9,341.00
13,845.00
Net Tangible Assets
43,025.00
98,767.00
187,286.00
112,673.00
Working Capital
97,014.00
155,841.00
130,537.00
55,491.00
Invested Capital
112,540.00
244,433.00
187,338.00
112,746.00
Tangible Book Value
43,025.00
98,767.00
187,286.00
112,673.00
Total Debt
111,458.00
114,281.00
9,341.00
13,845.00
Share Issued
96,804.35
96,263.17
86,175.06
82,320.59
Ordinary Shares Number
96,804.35
96,263.17
86,175.06
82,320.59
12/31/2020 - 12/13/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SCLP.L Scancell Holdings plc
10.85
+0.93%
BIOSGN.ST Biosergen AB
0.6160
+0.33%
EVLO Evelo Biosciences, Inc.
0.0005
+25.00%
AVCT.L Avacta Group Plc
45.75
+6.40%
HVO.L hVIVO plc
20.75
-4.38%
8F8.SG SynAct Pharma AB
0.8515
-2.63%
MODTX.ST Modus Therapeutics Holding AB (publ)
1.8800
+13.60%
IDOGEN.ST Idogen AB (publ)
0.1205
0.00%
8X4.F Nidhogg Resources Holding AB (publ)
0.0002
-66.67%
8F8.F SynAct Pharma AB
0.8285
-3.66%